Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Cancer Centre, Singapore
With
National Medical Research Council (NMRC), Singapore
Age
21–any
Sex
FEMALE
Healthy volunteers
Not accepted
You may be eligible if
Patients with histologically or cytologically proven metastatic TNBC
Patients whose TNBC has progressed after prior taxane therapy in the (neo)adjuvant or metastatic setting, and have not received Capecitabine or 5-fluorouracil
Females aged 21 years and older
ECOG performance status 0 or 1
Life expectancy greater than three months
Patients have normal organ and marrow function
Site(s) of disease amenable to serial bedside biopsies before, during and after study treatment
You may not be if
Previous palliative radiotherapy to potentially biopsy-able lesion
Active symptomatic central nervous system (CNS) metastases
Spinal cord compression not definitively treated with surgery and/or radiation
